Sleep Aids (Pharmacies) - United Arab Emirates

  • United Arab Emirates
  • Revenue in the Sleep Aids market is projected to reach US$2.06m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.69%, resulting in a market volume of US$1.99m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.21 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in United Arab Emirates has experienced significant growth in recent years, driven by customer preferences for improving sleep quality and the local special circumstances in the country.

Customer preferences:
Customers in United Arab Emirates have shown a growing interest in sleep aids as they become more aware of the importance of a good night's sleep for overall health and well-being. With the fast-paced and stressful lifestyles in the country, many individuals are seeking ways to improve their sleep quality and address issues such as insomnia and sleep disturbances. As a result, there has been a rise in the demand for sleep aids in pharmacies.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in United Arab Emirates is the increasing availability and variety of sleep aids in pharmacies. Pharmacies in the country are stocking a wide range of sleep aids, including over-the-counter medications, herbal supplements, and natural remedies. This trend is driven by the growing demand from customers who are looking for convenient and accessible solutions to their sleep problems. Another trend in the market is the rising popularity of natural and herbal sleep aids. Customers in United Arab Emirates are increasingly seeking natural alternatives to traditional medications, driven by concerns about potential side effects and a preference for holistic approaches to health. This has led to the introduction of a variety of herbal sleep aids in pharmacies, which cater to this specific customer preference.

Local special circumstances:
The Sleep Aids (Pharmacies) market in United Arab Emirates is also influenced by the local special circumstances in the country. The high prevalence of stress and anxiety among the population, coupled with the fast-paced lifestyle, has contributed to the demand for sleep aids. Additionally, the presence of a large expatriate population in the country, who may experience jet lag or have difficulty adjusting to the local time zone, further drives the need for sleep aids.

Underlying macroeconomic factors:
The growth of the Sleep Aids (Pharmacies) market in United Arab Emirates can also be attributed to underlying macroeconomic factors. The country has a strong economy and high disposable income levels, which enable individuals to afford sleep aids and prioritize their sleep health. Furthermore, the government's focus on healthcare and wellness initiatives has raised awareness about the importance of sleep, leading to increased demand for sleep aids. In conclusion, the Sleep Aids (Pharmacies) market in United Arab Emirates is experiencing growth due to customer preferences for improving sleep quality, the availability of a wide range of sleep aids in pharmacies, local special circumstances such as high stress levels and a large expatriate population, and underlying macroeconomic factors such as a strong economy and government focus on healthcare. This market is likely to continue growing as individuals prioritize their sleep health and seek convenient and accessible solutions to their sleep problems.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)